We sit down with you and build your perfect lead list. Book a call with founders.

SiftrBio Analysis: $1M Raised

What is SiftrBio?

Next-generation ADC development platform

Funding Category
Seed

Product Features & Capabilities

  • SIFTR platform for ADC linker development
  • High throughput linker design
  • Human tissue-based linker optimization

Other Considerations

Received £1 million investment for ADC development; Awarded £827K grant from EPSRC for ADC linker research; Backed by Imperial College and Cancer Research Horizons

Find more companies like SiftrBio

VC-backed University Spinouts